Europe Human microbiome Market to Reach US$ 346.67 Mn at CAGR of 22.2% by 2025

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Human Microbiome Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Human Microbiome Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Significant investment in research and development likely drives advancements in precision medicine and therapeutic interventions.

5.2 Market Opportunities

5.2.1 Robust Investment in Research and Development

5.3 Future Trends

5.3.1 The emergence of precision medicine is likely to act as a key trend in the market in the coming years

5.4 Impact of Drivers and Restraints

6. Europe Human Microbiome Market Regional Analysis

6.1 Europe Human Microbiome Market Overview

6.2 Europe Human Microbiome Market Revenue 2015-2025 (US$ Million)

6.3 Europe Human Microbiome Market Forecast Analysis

7. Europe Human Microbiome Market Analysis – by Product

7.1 Probiotics

7.1.1 Overview
7.1.2 Probiotics: Europe Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Foods

7.2.1 Overview
7.2.2 Foods: Europe Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Prebiotics

7.3.1 Overview
7.3.2 Prebiotics: Europe Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Medical Foods

7.4.1 Overview
7.4.2 Medical Foods: Europe Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Diagnostic Device

7.5.1 Overview
7.5.2 Diagnostic Device: Europe Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)

7.6 Drugs

7.6.1 Overview
7.6.2 Drugs: Europe Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)

7.7 Supplements

7.7.1 Overview
7.7.2 Supplements: Europe Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Human Microbiome Market Analysis – by Disease

8.1 Obesity

8.1.1 Overview
8.1.2 Obesity: Europe Human Microbiome Market – Revenue and Forecast to 2025 (US$ Million)

8.2 Diabetes

8.2.1 Overview
8.2.2 Diabetes: Europe Human Microbiome Market – Revenue and Forecast to 2025 (US$ Million)

8.3 Autoimmune Disorders

8.3.1 Overview
8.3.2 Autoimmune Disorders: Europe Human Microbiome Market – Revenue and Forecast to 2025 (US$ Million)

8.4 Cancer

8.4.1 Overview
8.4.2 Cancer: Europe Human Microbiome Market – Revenue and Forecast to 2025 (US$ Million)

8.5 Mental Disorders

8.5.1 Overview
8.5.2 Mental Disorders: Europe Human Microbiome Market – Revenue and Forecast to 2025 (US$ Million)

9. Europe Human Microbiome Market Analysis – by Application

9.1 Therapeutics

9.1.1 Overview
9.1.2 Mental Disorders: Europe Human Microbiome Market – Revenue and Forecast to 2025 (US$ Million)

9.2 Diagnostics

9.2.1 Overview
9.2.2 Mental Disorders: Europe Human Microbiome Market – Revenue and Forecast to 2025 (US$ Million)

10. Europe Human Microbiome Market – Europe Analysis

10.1 Europe

10.1.1 Europe Human Microbiome Market Breakdown, by Key Country, 2018 and 2025 (%)
10.1.1.1 Europe Human Microbiome Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Human Microbiome Market – Revenue and Forecast to 2025 (US$ Million)

10.1.1.1.1 UK: Europe Human Microbiome Market Breakdown, by Product
10.1.1.1.2 UK: Europe Human Microbiome Market Breakdown, by Disease
10.1.1.1.3 UK: Europe Human Microbiome Market Breakdown, by Application

10.1.1.2 Germany: Europe Human Microbiome Market – Revenue and Forecast to 2025 (US$ Million)

10.1.1.2.1 Germany: Europe Human Microbiome Market Breakdown, by Product
10.1.1.2.2 Germany: Europe Human Microbiome Market Breakdown, by Disease
10.1.1.2.3 Germany: Europe Human Microbiome Market Breakdown, by Application

10.1.1.3 France: Europe Human Microbiome Market – Revenue and Forecast to 2025 (US$ Million)

10.1.1.3.1 France: Europe Human Microbiome Market Breakdown, by Product
10.1.1.3.2 France: Europe Human Microbiome Market Breakdown, by Disease
10.1.1.3.3 France: Europe Human Microbiome Market Breakdown, by Application

10.1.1.4 Russia: Europe Human Microbiome Market – Revenue and Forecast to 2025 (US$ Million)

10.1.1.4.1 Russia: Europe Human Microbiome Market Breakdown, by Product
10.1.1.4.2 Russia: Europe Human Microbiome Market Breakdown, by Disease
10.1.1.4.3 Russia: Europe Human Microbiome Market Breakdown, by Application

10.1.1.5 Italy: Europe Human Microbiome Market – Revenue and Forecast to 2025 (US$ Million)

10.1.1.5.1 Italy: Europe Human Microbiome Market Breakdown, by Product
10.1.1.5.2 Italy: Europe Human Microbiome Market Breakdown, by Disease
10.1.1.5.3 Italy: Europe Human Microbiome Market Breakdown, by Application

10.1.1.6 Rest of Europe: Europe Human Microbiome Market – Revenue and Forecast to 2025 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Human Microbiome Market Breakdown, by Product
10.1.1.6.2 Rest of Europe: Europe Human Microbiome Market Breakdown, by Disease
10.1.1.6.3 Rest of Europe: Europe Human Microbiome Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Human Microbiome Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Enterome

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 MicroBiome Therapeutics, LLC

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Rebiotix Inc.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Yakult Honsha Co., Ltd.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Osel Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Vedanta Biosciences, Inc.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Metabiomics Corporate

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Synthetic Biologics, Inc.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 DuPont

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 BiomX Ltd.

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights